TOMI Secures Regulatory Approval for Disinfection Technology in the UK
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 23 2026
0mins
Should l Buy TOMZ?
Source: stocktwits
- Regulatory Approval: TOMI Environmental Solutions, Inc. announced that its Binary Ionization Technology (BIT) and SteraMist iHP equipment have received formal approval from the UK's Health and Safety Executive, marking a significant step for commercial use in England, Scotland, and Wales, thereby expanding sales opportunities in the UK market.
- Product Coverage: The approval encompasses both room fogging systems and handheld spray applications, capable of effectively disinfecting cleaned hard, non-porous surfaces, including floors, walls, and furnishings, with efficacy against bacteria, yeast, and viruses observable in as little as five minutes, while fogging protocols may take up to 15 minutes.
- Positive Market Reaction: Following the approval, TOMI's stock surged over 23% in pre-market trading on Monday, reflecting optimistic market sentiment towards the company's prospects, as retail investor sentiment shifted from neutral to bullish, indicating expectations for future sales growth.
- Future Outlook: TOMI COO Elissa J. Shane expressed optimism regarding the company's application under the EU Biocidal Products Regulation, anticipating approval this year, which would open doors in additional European countries and further drive business growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TOMZ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TOMZ
Wall Street analysts forecast TOMZ stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.690
Low
3.50
Averages
3.50
High
3.50
Current: 0.690
Low
3.50
Averages
3.50
High
3.50
About TOMZ
TOMI Environmental Solutions, Inc. is a bacteria decontamination and infectious disease control company. The Company is engaged in offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. The Company utilizes its Binary Ionization Technology (BIT) platform through its SteraMist brand of products. Its flagship product, SteraMist, uses its patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. SteraMist generates ionized Hydrogen Peroxide (iHP) using cold plasma science. Its products and services include SteraPak, SteraMist Surface Unit, SteraMist Environment System, SteraMist Total Disinfection Cart, SteraMist Transport, NV+, SteraMist Custom Engineered System, Hybrid, SteraMist Integrated System, Stainless Steel 90 Degree Applicator and iHP Corporate Service Decontamination.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Keysight Technologies Quarterly Earnings Beat Estimates
- Strong Earnings Performance: Keysight Technologies reported earnings per share of $2.17, exceeding Wall Street's expectation of $2, demonstrating robust profitability that boosts investor confidence.
- Significant Revenue Growth: The quarterly revenue reached $1.6 billion, surpassing the analyst consensus of $1.54 billion, indicating successful business expansion and strong market demand, further solidifying its market position.
- Stock Price Surge: Keysight's shares jumped 16.8% to $286.03 in pre-market trading, reflecting a positive investor reaction to the company's financial performance, which may attract more investor interest.
- Market Dynamics Impact: Keysight's strong results could influence the performance of other related stocks, particularly in the technology and electronics sectors, signaling an overall improvement in market sentiment.
See More
TOMI Receives UK Authorization for BIT Technology
- Authorization Breakthrough: TOMI Environmental Solutions announced that its Binary Ionization Technology (BIT) has received official authorization in Great Britain, marking a pivotal achievement that allows the company to expand its product offerings in both Great Britain and Northern Ireland, which is expected to significantly enhance market share.
- Wide Market Application: The BIT solution is approved for use as a microbial disinfectant on surfaces in healthcare, industrial, commercial, hospitality, and institutional settings under Regulation 528/2012, further strengthening the company's competitive position across multiple sectors.
- Optimistic Financial Outlook: The company is expected to report its next financial update on April 13, 2026, with EPS estimates improving from a loss of 5 cents to a loss of 2 cents, and revenue estimates rising from $1.07 million to $2.31 million, indicating strong business growth potential.
- Strong Stock Performance: TOMI's shares rose 1.87% to $0.71 during premarket trading on Monday, with the current stock price trading 8.33% above the 20-day and 12.5% above the 100-day simple moving averages, reflecting a strong short-term market performance.
See More
TOMI Secures Regulatory Approval for Disinfection Technology in the UK
- Regulatory Approval: TOMI Environmental Solutions, Inc. announced that its Binary Ionization Technology (BIT) and SteraMist iHP equipment have received formal approval from the UK's Health and Safety Executive, marking a significant step for commercial use in England, Scotland, and Wales, thereby expanding sales opportunities in the UK market.
- Product Coverage: The approval encompasses both room fogging systems and handheld spray applications, capable of effectively disinfecting cleaned hard, non-porous surfaces, including floors, walls, and furnishings, with efficacy against bacteria, yeast, and viruses observable in as little as five minutes, while fogging protocols may take up to 15 minutes.
- Positive Market Reaction: Following the approval, TOMI's stock surged over 23% in pre-market trading on Monday, reflecting optimistic market sentiment towards the company's prospects, as retail investor sentiment shifted from neutral to bullish, indicating expectations for future sales growth.
- Future Outlook: TOMI COO Elissa J. Shane expressed optimism regarding the company's application under the EU Biocidal Products Regulation, anticipating approval this year, which would open doors in additional European countries and further drive business growth.
See More
TOMI Receives Approval for Disinfection Technology in the UK
- Regulatory Milestone: TOMI Environmental Solutions, Inc. has received official authorization for its Binary Ionization Technology (BIT) solution from the Health and Safety Executive in Great Britain, marking a significant step in expanding its market presence in both Great Britain and Northern Ireland under Regulation 528/2012, thereby enhancing its competitive position in the disinfection industry.
- Product Application Scope: The BIT solution is approved for room fogging and handheld spray applications, intended for use across various sectors including healthcare, industrial, and commercial, which is expected to significantly boost the company's sales potential and customer base in these critical markets.
- Optimistic Market Outlook: COO Elissa J. Shane expressed optimism about the approval in the UK and anticipates that the application for the EU will also be approved, which would further expand business opportunities in Europe and strengthen the company's competitive edge in international markets.
- Technological Advantage: The SteraMist products utilize a low percentage of Hydrogen Peroxide as the sole active ingredient, producing an ionized Hydrogen Peroxide fog that effectively kills germs, making it suitable for hospitals, schools, restaurants, and more, thereby enhancing the company's influence in public health sectors.
See More
TOMI Adopts SteraMist Technology to Enhance CGT Manufacturing Standards
- Technology Adoption: TOMI Environmental Solutions, Inc. announced that a leading Cell and Gene Therapy manufacturer has adopted SteraMist ionized Hydrogen Peroxide technology to enhance its contamination control strategy, ensuring compliance with stringent current Good Manufacturing Practices (cGMP).
- Investment Scale: The client has invested in multiple SteraMist systems for surface treatment and automated room fogging, which not only elevates production efficiency but also enhances customer trust in their products by ensuring the highest safety standards.
- Comprehensive Service: TOMI's iHP Corporate Service team will perform a comprehensive whole-facility fogging service covering all critical areas, including manufacturing suites and quality control labs, ensuring a sterile environment for critical pharmaceutical processes.
- Market Demand: The rapid expansion of Cell and Gene Therapy and 503B compounding drives TOMI to remain at the forefront of providing specialized, scalable solutions tailored to the stringent requirements of these high-growth sectors, addressing future market needs effectively.
See More
TOMI Secures $500,000 Contract for SteraMist Integration with Major Biopharma
- Contract Signing: TOMI Environmental Solutions has secured a purchase contract valued at approximately $500,000 with one of the world's leading biopharmaceutical companies to integrate its SteraMist Integrated Systems into critical manufacturing infrastructure, enhancing production efficiency.
- Technology Application: The contract mandates the use of SteraMist iHP technology in the client's sterile manufacturing process, ensuring rapid, residue-free decontamination across two separate areas while meeting stringent biopharmaceutical regulatory requirements.
- Market Demand: Launched in late 2024, the SteraMist Integrated System is designed to meet the escalating industry demand for automated, high-throughput decontamination, with a robust pipeline of orders anticipated throughout 2026 and beyond.
- Strategic Collaboration: TOMI's COO highlighted the increasing opportunities to collaborate with large pharmaceutical organizations, indicating the efficacy of SteraMist technology in meeting rigorous validation and throughput requirements, thereby further solidifying the company's market position in the biopharmaceutical sector.
See More
Keysight Technologies Quarterly Earnings Beat Estimates
- Strong Earnings Performance: Keysight Technologies reported earnings per share of $2.17, exceeding Wall Street's expectation of $2, demonstrating robust profitability that boosts investor confidence.
- Significant Revenue Growth: The quarterly revenue reached $1.6 billion, surpassing the analyst consensus of $1.54 billion, indicating successful business expansion and strong market demand, further solidifying its market position.
- Stock Price Surge: Keysight's shares jumped 16.8% to $286.03 in pre-market trading, reflecting a positive investor reaction to the company's financial performance, which may attract more investor interest.
- Market Dynamics Impact: Keysight's strong results could influence the performance of other related stocks, particularly in the technology and electronics sectors, signaling an overall improvement in market sentiment.
See More
TOMI Receives UK Authorization for BIT Technology
- Authorization Breakthrough: TOMI Environmental Solutions announced that its Binary Ionization Technology (BIT) has received official authorization in Great Britain, marking a pivotal achievement that allows the company to expand its product offerings in both Great Britain and Northern Ireland, which is expected to significantly enhance market share.
- Wide Market Application: The BIT solution is approved for use as a microbial disinfectant on surfaces in healthcare, industrial, commercial, hospitality, and institutional settings under Regulation 528/2012, further strengthening the company's competitive position across multiple sectors.
- Optimistic Financial Outlook: The company is expected to report its next financial update on April 13, 2026, with EPS estimates improving from a loss of 5 cents to a loss of 2 cents, and revenue estimates rising from $1.07 million to $2.31 million, indicating strong business growth potential.
- Strong Stock Performance: TOMI's shares rose 1.87% to $0.71 during premarket trading on Monday, with the current stock price trading 8.33% above the 20-day and 12.5% above the 100-day simple moving averages, reflecting a strong short-term market performance.
See More
TOMI Secures Regulatory Approval for Disinfection Technology in the UK
- Regulatory Approval: TOMI Environmental Solutions, Inc. announced that its Binary Ionization Technology (BIT) and SteraMist iHP equipment have received formal approval from the UK's Health and Safety Executive, marking a significant step for commercial use in England, Scotland, and Wales, thereby expanding sales opportunities in the UK market.
- Product Coverage: The approval encompasses both room fogging systems and handheld spray applications, capable of effectively disinfecting cleaned hard, non-porous surfaces, including floors, walls, and furnishings, with efficacy against bacteria, yeast, and viruses observable in as little as five minutes, while fogging protocols may take up to 15 minutes.
- Positive Market Reaction: Following the approval, TOMI's stock surged over 23% in pre-market trading on Monday, reflecting optimistic market sentiment towards the company's prospects, as retail investor sentiment shifted from neutral to bullish, indicating expectations for future sales growth.
- Future Outlook: TOMI COO Elissa J. Shane expressed optimism regarding the company's application under the EU Biocidal Products Regulation, anticipating approval this year, which would open doors in additional European countries and further drive business growth.
See More
TOMI Receives Approval for Disinfection Technology in the UK
- Regulatory Milestone: TOMI Environmental Solutions, Inc. has received official authorization for its Binary Ionization Technology (BIT) solution from the Health and Safety Executive in Great Britain, marking a significant step in expanding its market presence in both Great Britain and Northern Ireland under Regulation 528/2012, thereby enhancing its competitive position in the disinfection industry.
- Product Application Scope: The BIT solution is approved for room fogging and handheld spray applications, intended for use across various sectors including healthcare, industrial, and commercial, which is expected to significantly boost the company's sales potential and customer base in these critical markets.
- Optimistic Market Outlook: COO Elissa J. Shane expressed optimism about the approval in the UK and anticipates that the application for the EU will also be approved, which would further expand business opportunities in Europe and strengthen the company's competitive edge in international markets.
- Technological Advantage: The SteraMist products utilize a low percentage of Hydrogen Peroxide as the sole active ingredient, producing an ionized Hydrogen Peroxide fog that effectively kills germs, making it suitable for hospitals, schools, restaurants, and more, thereby enhancing the company's influence in public health sectors.
See More
TOMI Adopts SteraMist Technology to Enhance CGT Manufacturing Standards
- Technology Adoption: TOMI Environmental Solutions, Inc. announced that a leading Cell and Gene Therapy manufacturer has adopted SteraMist ionized Hydrogen Peroxide technology to enhance its contamination control strategy, ensuring compliance with stringent current Good Manufacturing Practices (cGMP).
- Investment Scale: The client has invested in multiple SteraMist systems for surface treatment and automated room fogging, which not only elevates production efficiency but also enhances customer trust in their products by ensuring the highest safety standards.
- Comprehensive Service: TOMI's iHP Corporate Service team will perform a comprehensive whole-facility fogging service covering all critical areas, including manufacturing suites and quality control labs, ensuring a sterile environment for critical pharmaceutical processes.
- Market Demand: The rapid expansion of Cell and Gene Therapy and 503B compounding drives TOMI to remain at the forefront of providing specialized, scalable solutions tailored to the stringent requirements of these high-growth sectors, addressing future market needs effectively.
See More
TOMI Secures $500,000 Contract for SteraMist Integration with Major Biopharma
- Contract Signing: TOMI Environmental Solutions has secured a purchase contract valued at approximately $500,000 with one of the world's leading biopharmaceutical companies to integrate its SteraMist Integrated Systems into critical manufacturing infrastructure, enhancing production efficiency.
- Technology Application: The contract mandates the use of SteraMist iHP technology in the client's sterile manufacturing process, ensuring rapid, residue-free decontamination across two separate areas while meeting stringent biopharmaceutical regulatory requirements.
- Market Demand: Launched in late 2024, the SteraMist Integrated System is designed to meet the escalating industry demand for automated, high-throughput decontamination, with a robust pipeline of orders anticipated throughout 2026 and beyond.
- Strategic Collaboration: TOMI's COO highlighted the increasing opportunities to collaborate with large pharmaceutical organizations, indicating the efficacy of SteraMist technology in meeting rigorous validation and throughput requirements, thereby further solidifying the company's market position in the biopharmaceutical sector.
See More
